A share price of CVS Health Corp [CVS] is currently trading at $64.48, up 0.97%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CVS shares have lost -0.94% over the last week, with a monthly amount glided 12.47%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on February 13, 2025, when Leerink Partners upgraded its rating to a Outperform and also boosted its price target to $75 from $55. Previously, Cantor Fitzgerald upgraded its rating to Overweight on February 12, 2025. On January 30, 2025, upgrade upgraded it’s rating to Buy. Deutsche Bank upgraded its rating to a Buy but stick to its price target of $66 on December 03, 2024. Wells Fargo upgraded its rating to a Overweight and raised its price target to $66 on November 18, 2024. Barclays upgraded its rating to Overweight for this stock on October 10, 2024, and upped its price target to $82. In a note dated October 04, 2024, TD Cowen upgraded an Buy rating on this stock and boosted its target price from $59 to $85.
CVS Health Corp experienced fluctuations in its stock price throughout the past year between $43.56 and $80.75. Currently, Wall Street analysts expect the stock to reach $71.33 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $64.48 at the most recent close of the market. An investor can expect a potential return of 10.62% based on the average CVS price forecast.
Analyzing the CVS fundamentals
Trailing Twelve Months sales for CVS Health Corp [NYSE:CVS] were 372.69B which represents 3.77% growth. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.06 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 63.82 points at the first support level, and at 63.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 65.09, and for the 2nd resistance point, it is at 65.69.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CVS Health Corp [NYSE:CVS] is 0.81. Further, the Quick Ratio stands at 0.60, while the Cash Ratio is 0.1. Considering the valuation of this stock, the price to sales ratio is 0.22, the price to book ratio is 1.08 and price to earnings (TTM) ratio is 17.63.
Transactions by insiders
Recent insider trading involved Mahoney Michael F, Director, that happened on Feb 18 ’25 when 30000.0 shares were purchased. Director, LUDWIG EDWARD J completed a deal on May 02 ’24 to buy 1000.0 shares. Meanwhile, Director Mahoney Michael F bought 9181.0 shares on May 02 ’24.
